Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124681823 | 12468182 | 3 | F | 20160517 | 20160630 | 20160615 | 20160707 | EXP | RO-KADMON PHARMACEUTICALS, LLC-KAD201606-002147 | KADMON | 63.04 | YR | F | Y | 0.00000 | 20160707 | MD | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124681823 | 12468182 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 3 IN THE MORNING AND 3 IN THE EVENING | N | 77456 | |||||||||
| 124681823 | 12468182 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 1 IN THE MORNING AND 2 IN THE EVENING | N | 77456 | |||||||||
| 124681823 | 12468182 | 3 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 0 | |||||||||||
| 124681823 | 12468182 | 4 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 0 | ||||||||||||
| 124681823 | 12468182 | 5 | SS | Exviera | DASABUVIR | 1 | Oral | 0 | |||||||||||
| 124681823 | 12468182 | 6 | SS | Exviera | DASABUVIR | 1 | 0 | ||||||||||||
| 124681823 | 12468182 | 7 | C | Euthyrox | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | |||||||||||
| 124681823 | 12468182 | 8 | C | Enalapril | ENALAPRIL | 1 | Oral | 0 | |||||||||||
| 124681823 | 12468182 | 9 | C | Nitromint | 2 | Oral | 0 | ||||||||||||
| 124681823 | 12468182 | 10 | C | NEBIVOLOL. | NEBIVOLOL | 1 | 0 | 5 | MG | ||||||||||
| 124681823 | 12468182 | 11 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 0 | 2.5 | MG | |||||||||
| 124681823 | 12468182 | 12 | C | Aspenter | ASPIRIN | 1 | Oral | 0 | |||||||||||
| 124681823 | 12468182 | 13 | C | Ampril | 2 | Oral | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124681823 | 12468182 | 1 | Hepatitis C |
| 124681823 | 12468182 | 2 | Hepatic cirrhosis |
| 124681823 | 12468182 | 3 | Hepatitis C |
| 124681823 | 12468182 | 4 | Hepatic cirrhosis |
| 124681823 | 12468182 | 5 | Hepatitis C |
| 124681823 | 12468182 | 6 | Hepatic cirrhosis |
| 124681823 | 12468182 | 7 | Hypothyroidism |
| 124681823 | 12468182 | 8 | Hypertension |
| 124681823 | 12468182 | 9 | Angina pectoris |
| 124681823 | 12468182 | 10 | Hypertension |
| 124681823 | 12468182 | 11 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124681823 | 12468182 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124681823 | 12468182 | Headache | |
| 124681823 | 12468182 | Oedema peripheral | |
| 124681823 | 12468182 | Oliguria | |
| 124681823 | 12468182 | Optic neuritis | |
| 124681823 | 12468182 | Pain in extremity | |
| 124681823 | 12468182 | Spinal pain | |
| 124681823 | 12468182 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124681823 | 12468182 | 1 | 20160514 | 0 | ||
| 124681823 | 12468182 | 2 | 20160610 | 0 | ||
| 124681823 | 12468182 | 3 | 20160514 | 0 | ||
| 124681823 | 12468182 | 5 | 20160514 | 0 | ||
| 124681823 | 12468182 | 7 | 1996 | 0 | ||
| 124681823 | 12468182 | 11 | 2013 | 0 | ||
| 124681823 | 12468182 | 13 | 1986 | 0 |